CliffBio
small molecule

EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

EPINEPHRINE BITARTRATE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameEPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Active ingredientEPINEPHRINE BITARTRATE
StrengthEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalFebruary 2025
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.